These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 8120863)

  • 1. Potent gastrin-releasing peptide (GRP) antagonists derived from GRP (19-27) with a C-terminal DPro psi [CH2NH]Phe-NH2 and N-terminal aromatic residues.
    Leban JJ; Landavazo A; McDermed JD; Diliberto EJ; Jansen M; Stockstill B; Kull FC
    J Med Chem; 1994 Feb; 37(4):439-45. PubMed ID: 8120863
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of potent gastrin-releasing peptide antagonists having a D-Pro-psi(CH2NH)-Phe-NH2 C terminus.
    Leban JJ; Kull FC; Landavazo A; Stockstill B; McDermed JD
    Proc Natl Acad Sci U S A; 1993 Mar; 90(5):1922-6. PubMed ID: 8446610
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design, structure-activity, and molecular modeling studies of potent renin inhibitory peptides having N-terminal Nin-For-Trp (Ftr): angiotensinogen congeners modified by P1-P1' Phe-Phe, Sta, Leu psi[CH(OH)CH2]Val or leu psi[CH2NH]Val substitutions.
    Sawyer TK; Pals DT; Mao B; Staples DJ; de Vaux AE; Maggiora LL; Affholter JA; Kati W; Duchamp D; Hester JB
    J Med Chem; 1988 Jan; 31(1):18-30. PubMed ID: 3275777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and biological activities of pseudopeptide analogues of the C-terminal heptapeptide of cholecystokinin. On the importance of the peptide bonds.
    Rodriguez M; Lignon MF; Galas MC; Fulcrand P; Mendre C; Aumelas A; Laur J; Martinez J
    J Med Chem; 1987 Aug; 30(8):1366-73. PubMed ID: 2441054
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pseudononapeptide bombesin antagonists containing C-terminal Trp or Tpi.
    Cai RZ; Radulovic S; Pinski J; Nagy A; Redding TW; Olsen DB; Schally AV
    Peptides; 1992; 13(2):267-71. PubMed ID: 1409006
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis of pseudo-peptide analogues of the C-terminal tetrapeptide of gastrin and evaluation of their biological activity on acid secretion.
    Rodriguez M; Bali JP; Magous R; Castro B; Martinez J
    Int J Pept Protein Res; 1986 Mar; 27(3):293-9. PubMed ID: 3011690
    [TBL] [Abstract][Full Text] [Related]  

  • 7. N-isobutyryl-His-Trp-Ala-Val-D-Ala-His-Leu-NHMe (ICI 216140) a potent in vivo antaconist analogue of bombesin/gastrin releasing peptide (BN/GRP) derived from the C-terminal sequence lacking the final methionine residue.
    Camble R; Cotton R; Dutta AS; Garner A; Hayward CF; Moore VE; Scholes PB
    Life Sci; 1989; 45(17):1521-7. PubMed ID: 2555638
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antagonists of bombesin/gastrin releasing peptide based on [D-Ala24]GRP(20-26)-heptapeptide. Modifications leading to potent analogues with prolonged duration of action.
    Best JR; Cotton R; Dutta AS; Fleming B; Garner A; Gormley JJ; Hayward CF; McLachlan PF; Scholes PB
    Drug Des Deliv; 1990 Oct; 6(4):255-71. PubMed ID: 1707276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carboxyl-terminal modification of a gastrin releasing peptide derivative generates potent antagonists.
    Heimbrook DC; Saari WS; Balishin NL; Friedman A; Moore KS; Reimen MW; Kiefer DM; Rotberg NS; Wallen JW; Oliff A
    J Biol Chem; 1989 Jul; 264(19):11258-62. PubMed ID: 2544588
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure-activity relationships of the unique and potent agouti-related protein (AGRP)-melanocortin chimeric Tyr-c[beta-Asp-His-DPhe-Arg-Trp-Asn-Ala-Phe-Dpr]-Tyr-NH2 peptide template.
    Wilczynski A; Wilson KR; Scott JW; Edison AS; Haskell-Luevano C
    J Med Chem; 2005 Apr; 48(8):3060-75. PubMed ID: 15828845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endocrine effects of new bombesin/gastrin-releasing peptide antagonists in rats.
    Pinski J; Yano T; Groot K; Cai RZ; Radulovic S; Schally AV
    Am J Physiol; 1992 Oct; 263(4 Pt 1):E712-7. PubMed ID: 1415689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative analysis of various proposed models of the receptor-bound conformation of H-Tyr-Tic-Phe-OH related delta-opioid antagonists.
    Wilkes BC; Schiller PW
    Biopolymers; 1995; 37(6):391-400. PubMed ID: 8589244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Superactive octapeptide somatostatin analogs containing tryptophan at position 1.
    Cai RZ; Karashima T; Guoth J; Szoke B; Olsen D; Schally AV
    Proc Natl Acad Sci U S A; 1987 Apr; 84(8):2502-6. PubMed ID: 2882520
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of putative agouti-related protein(87-132)-melanocortin-4 receptor interactions by homology molecular modeling and validation using chimeric peptide ligands.
    Wilczynski A; Wang XS; Joseph CG; Xiang Z; Bauzo RM; Scott JW; Sorensen NB; Shaw AM; Millard WJ; Richards NG; Haskell-Luevano C
    J Med Chem; 2004 Apr; 47(9):2194-207. PubMed ID: 15084118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peptide structural requirements for antagonism differ between the two mammalian bombesin receptor subtypes.
    Lin JT; Coy DH; Mantey SA; Jensen RT
    J Pharmacol Exp Ther; 1995 Oct; 275(1):285-95. PubMed ID: 7562561
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endomorphin 1[psi] and endomorphin 2[psi], endomorphins analogues containing a reduced (CH2NH) amide bond between Tyr1 and Pro2, display partial agonist potency but significant antinociception.
    Zhao QY; Chen Q; Yang DJ; Feng Y; Long Y; Wang P; Wang R
    Life Sci; 2005 Jul; 77(10):1155-65. PubMed ID: 15878600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Psi [CH2NH] backbone-modified peptides: first unequivocal observation of a C7 structure in a linear peptide.
    Toniolo C; Valle G; Crisma M; Kaltenbronn JS; Repine JT; Van Binst G; Elseviers M; Tourwé D
    Pept Res; 1989; 2(5):332-7. PubMed ID: 2520771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis of peptide and pseudopeptide amides inhibiting the proliferation of small cell and epithelial types of lung carcinoma cells.
    Nyéki O; Rill A; Schon I; Orosz A; Schrett J; Bartha L; Nagy J
    J Pept Sci; 1998 Dec; 4(8):486-95. PubMed ID: 9927255
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systematic development of bombesin/gastrin-releasing peptide antagonists.
    Coy DH; Jensen RT; Jiang NY; Lin JT; Bogden AE; Moreau JP
    J Natl Cancer Inst Monogr; 1992; (13):133-9. PubMed ID: 1389686
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A gastrin-releasing peptide antagonist containing A psi (CH2O) amide bond surrogate.
    Saari WS; Heimbrook DC; Friedman A; Fisher TW; Oliff A
    Biochem Biophys Res Commun; 1989 Nov; 165(1):114-7. PubMed ID: 2590213
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.